GHG emissions in TAHs. by Jure Brečko (20314959)

“…At the sector level, the gross margin decreased by 12% in 2020 but increased by 99% in 2022 compared to the reference year 2018, highlighting the incredible price volatility over a short period. …”

Survival function analysis of mortality for Viral load status and Treatment Interruption status. by Ekerette Emmanuel Udoh (7326194)

Subjects:

Multivariate Cox proportional hazard analysis ratio of patient factors associated with treatment outcomes in HIV care, 2020-2022. by Ekerette Emmanuel Udoh (7326194)

Subjects:

Clinic characteristics of study participants from two ART facilities in Bauchi state, based on data retrieved covering a three-year period from 2020 to 2022. by Ekerette Emmanuel Udoh (7326194)

Subjects:

Survival function analysis of treatment Interruption for Viral load status and BMI status. by Ekerette Emmanuel Udoh (7326194)

Subjects:

Survival function analysis of viral suppression for BMI status and Treatment Interruption status. by Ekerette Emmanuel Udoh (7326194)

Subjects:

Schematic presentation of sampling of population for analysis. by Ekerette Emmanuel Udoh (7326194)

Subjects:

Survival curve of ART Treatment outcomes. by Ekerette Emmanuel Udoh (7326194)

Subjects:

Incidence of mortality and viral load suppression by demographic characteristics among participants in HIV care facilities in Bauchi State, 2020-2022. by Ekerette Emmanuel Udoh (7326194)

Subjects:

Incidence of ART treatment interruption and LTFU by clinical characteristics <i>among participants in HIV care Facilities in</i> Bauchi State, 2020-2022. by Ekerette Emmanuel Udoh (7326194)

Subjects:

Incidence of ART treatment interruption and LTFU by demographic characteristics among participants in HIV care facilities in Bauchi State, 2020-2022. by Ekerette Emmanuel Udoh (7326194)

Subjects:

Incidence of mortality and viral load suppression by clinical characteristics among participants in HIV care facilities in Bauchi State, 2020-2022. by Ekerette Emmanuel Udoh (7326194)

Subjects:

Cumulative treatment outcomes prevalence rates for patients in ART treatment from year 2020 to 2022 for study participant in Bauchi State. by Ekerette Emmanuel Udoh (7326194)

Subjects:

Survival function analysis for LTFU according to Viral Load status and BMI status. by Ekerette Emmanuel Udoh (7326194)

Subjects:

Demographic characteristics of study participants from two ART facilities in Bauchi state, based on data retrieved covering a three-year period from 2020 to 2022. by Ekerette Emmanuel Udoh (7326194)

Subjects:

Annual incidence rate per 100 person-years trend for ART treatment outcomes. by Ekerette Emmanuel Udoh (7326194)

Subjects:

Model vs. WKY group KEGG pathways (Top 15). by Xiao Zhang (152326)

“…Characteristic metabolites in the model group, such as ATP, cAMP, Creatine, Cyanocobalamin, Dopamine, Serotonin, Tryptophan, Uric acid and Vitamin B1 decreased, while GABA, Glucose, Isocitrate and Malate increased.…”

Behavioral data. by Xiao Zhang (152326)

“…Characteristic metabolites in the model group, such as ATP, cAMP, Creatine, Cyanocobalamin, Dopamine, Serotonin, Tryptophan, Uric acid and Vitamin B1 decreased, while GABA, Glucose, Isocitrate and Malate increased.…”

OPLS-DA model parameter. by Xiao Zhang (152326)

“…Characteristic metabolites in the model group, such as ATP, cAMP, Creatine, Cyanocobalamin, Dopamine, Serotonin, Tryptophan, Uric acid and Vitamin B1 decreased, while GABA, Glucose, Isocitrate and Malate increased.…”

Model vs. SHR group KEGG pathways (Top 15). by Xiao Zhang (152326)

“…Characteristic metabolites in the model group, such as ATP, cAMP, Creatine, Cyanocobalamin, Dopamine, Serotonin, Tryptophan, Uric acid and Vitamin B1 decreased, while GABA, Glucose, Isocitrate and Malate increased.…”